Demand for liver transplant for NASH set to continue rising

August 24, 2017

(HealthDay)—Given population obesity trends, the increase in the demand for liver transplantation (LT) for nonalcoholic steatohepatitis (NASH) noted since 2000 is expected to continue, according to a study published online Aug. 17 in Hepatology.

Neehar D. Parikh, M.D., from the University of Michigan in Ann Arbor, and colleagues examined the temporal trend behind the increase in and NASH-related additions to the LT waitlist in the United States and made projections for future NASH burden on the LT waitlist. Data on the number of NASH-related LT waitlist additions were obtained from the Organ Procurement and Transplantation Network database from 2000 to 2014. During the same time period, data on the obese U.S. population were obtained from the U.S. Census Bureau and the National Health and Nutrition Examination Survey.

The researchers observed a significant increase of 44.9 percent in the proportion of obese individuals from 2000 to 2014, and the number of NASH-related annual waitlist additions increased from 391 to 1,605. In derivation and validation cohorts, there was a strong correlation for increase in the prevalence of obesity and LT waitlist additions nine years later (R² = 0.9). Between 2016 and 2030, the annual NASH-related waitlist additions were expected to increase by 55.4 percent. Significant regional variation was seen in obesity rates and the expected increase in NASH-related additions (P < 0.01).

"Continued public health efforts to curb obesity prevalence are needed to reduce the projected future burden of NASH," the authors write.

Explore further: Study sheds light on immune responses driving obesity-induced liver disease

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study sheds light on immune responses driving obesity-induced liver disease

June 28, 2017
New findings from mouse models reveal that the type of immune response that helps maintain healthy metabolism in fatty tissues, called type 2 immunity, also drives obesity-induced nonalcoholic fatty liver disease (NAFLD). ...

NASH ID'd by mass spectrometry-based profiling, clinical variables

October 6, 2016
(HealthDay)—Mass spectrometry (MS)-based profiling combined with clinical variables can identify nonalcoholic steatohepatitis (NASH), according to a study published in the October issue of Clinical Gastroenterology and ...

Weight loss benefits NASH, no matter how it's done

August 24, 2015
(HealthDay)—Weight loss can improve nonalcoholic steatohepatitis (NASH) in obese or overweight people, whether excess pounds are shed through lifestyle changes or weight-loss surgery, according to research published in ...

Obesity and diabetes epidemics spur increase in nonalcoholic steatohepatitis

December 14, 2011
Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity ...

Fatty liver: Turning off TAZ reverses disease

October 27, 2016
Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...

Recommended for you

Two Group A Streptococcus genes linked to 'flesh-eating' bacterial infections

September 22, 2017
Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known ...

Ecosystem approach makes urinary tract infection more treatable

September 22, 2017
The biological term 'ecosystem' is not usually associated with urinary tract infections, but this should change according to Wageningen scientists.

Residents: Frontline defenders against antibiotic resistance?

September 22, 2017
Antibiotic resistance continues to grow around the world, with sometimes disastrous results. Some strains of bacteria no longer respond to any currently available antibiotic, making death by infections that were once easily ...

Investigators may unlock mystery of how staph cells dodge the body's immune system

September 21, 2017
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the ...

Superbug's spread to Vietnam threatens malaria control

September 21, 2017
A highly drug resistant malaria 'superbug' from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine—Vietnam's national first-line malaria treatment, ...

Individualized diets for irritable bowel syndrome better than placebo

September 21, 2017
Patients with irritable bowel syndrome who follow individualized diets based on food sensitivity testing experience fewer symptoms, say Yale researchers. Their study is among the first to provide scientific evidence for this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.